ABSTRACT: Our group has previously developed immunoassays for noncompetitive detection of small molecules based on the use of phage borne anti-immunocomplex peptides. Recently, we substituted the phage particles by biotinylated synthetic anti-immunocomplex peptides complexed with streptavidin and named these constructs nanopeptamers. In this work, we report the results of combining AlphaLisa, a commercial luminescent oxygen channeling bead system, with nanopeptamers for the development of a noncompetitive homogeneous assay for the detection of small molecules. The signal generation of AlphaLisa assays relies on acceptor−donor bead proximity induced by the presence of the analyte (a macromolecule) simultaneously bound by antibodies immobilized on the surface of these beads. In the developed assay, termed as nanoAlphaLisa, bead proximity is sustained by the presence of a small model molecule (atrazine, MW = 215) using an antiatrazine antibody captured on the acceptor bead and an atrazine nanopeptamer on the donor bead. Atrazine is one of the most used pesticides worldwide, and its monitoring in water has relevant human health implications. NanoAlphaLisa allowed the homogeneous detection of atrazine down to 0.3 ng/mL in undiluted water samples in 1 h, which is 10-fold below the accepted limit in drinking water. NanoAlphaLisa has the intrinsic advantages for automation and high-throughput, simple, and fast homogeneous detection of target analytes that AlphaLisa assay provides.
I mmunoassays are simple, robust, and inexpensive analytical techniques based on the use of antibodies for detecting molecules of interest. One of the most known immunoassay formats is the enzyme linked immunosorbent assay (ELISA), which is considered a heterogeneous method because it requires several washing steps in between addition of reagents. On the other hand, mix and measure assays, which do not require washing steps because the reagents and sample are mixed and the readout is measured after a short incubation period, are classified as "homogeneous". Homogeneous assays are simpler to perform, take less time, and are easier to adapt to high throughput and automation than their heterogeneous counterparts.
In 2008, PerkinElmer Inc. first commercialized a luminescent oxygen channeling chemistry assay 1, 2 termed Amplified Luminescent Proximity Homogeneous Assay (AlphaLISA). In this assay, acceptor and donor beads bound to antibodies that recognize different epitopes of the antigen (typically a macromolecule) are brought together when the antigen is present, in a "sandwich" like format. Laser irradiation of donor beads at 680 nm generates a flow of singlet oxygen, triggering a cascade of chemical events in nearby acceptor beads, which results in a chemiluminescent emission at 615 nm. This assay has been widely used for the detection of macromolecules 3−11 and particles (spores), 12 but there are few references about its use for the detection of small molecules. 13 We have previously developed immunoassays for small molecule detection (haptens) using analyte peptidomimetics in a competitive format 14−16 and analyte−antibody anti-immunocomplexes peptides 17, 18 displayed on M13 viral particles in a noncompetitive format. These peptides were isolated by phage display technology and have been used in conventional ELISA, 15, 18 real-time immuno-PCR assays, 16 and electrochemical biosensors. 14, 19 Recently, we developed assays devoid of viral particles in which biotinylated anti-immunocomplex synthetic peptides complexed with a commercial streptavidin− peroxidase conjugate (referred to as nanopeptamers) were used as immunoassay reagents. 20 Also, nanopeptamers of recombinant nature where the anti-immunocomplex peptide is produced as a fusion with a multimeric protein have been used in conventional ELISA and lateral flow immunochromatography. 20−22 Nanopeptamers are more suitable reagents for the immunoassay industry than viral-based reagents, since E. coli infecting phages could be a matter of concern in some laboratories.
In this work, we report the results of combining AlphaLisa technology with an anti-immunocomplex nanopeptamer with the aim of developing a novel noncompetitive homogeneous immunoassay for the detection of small molecules. As a model target analyte, we chose to use atrazine, since it is one of the most heavily used pesticides worldwide and its detection in water has relevant human health implications: it is reported to be an endocrine disruptive chemical and a potential carcinogen. 23, 24 The atrazine nanopeptamer-based AlphaLisa, which we called nanoAlphaLisa, was successfully developed and exhibited excellent recoveries in river water samples, robustness, and sensitivities below the accepted limits in drinking water. 23, 24 Atrazine determination using this strategy was performed in 1 h. Given the toxicological, environmental, and medical analytical relevance of small molecules, this novel immunoassay prone to automation, high-throughput screening, and short incubation time can be adapted for the detection of these analytes.
■ MATERIALS AND METHODS
Materials. Atrazine and related triazines were a gift from Shirley Gee. The biotinylated synthetic peptides were supplied by a commercial manufacturer, Peptron, Inc. (Daejeon, South Korea). These peptides were synthesized to 80% purity by high-pressure liquid chromatography (HPLC), with intramolecular disulfides bonds between cysteines, an N-terminal biotin, and amidated C-terminus. AlphaLisa acceptor beads and streptavidin-coated donor beads were obtained from PerkinElmer (San Jose, CA, USA). High-sensitivity streptavidin peroxidase (SPO) and sodium cyanoborohydride were purchased from Thermo Scientific, Pierce (Rockford, IL). Bovine serum albumin (BSA), gelatin, protein A, Tween 20, 3,3, 5,5′-tetramethylbenzidine (TMB), and Corning White 96-well microplates (half area) were purchased from Sigma (St. Curves obtained using fixed amounts of streptavidin donor (7.5 μg/mL), protein A conjugated acceptor beads (10 μg/ mL), and different amounts of K4E7MoAb: 2.4 μg/mL (black squares), 1.2 μg/mL (black circles), 0.6 μg/mL (black triangles), 0.3 μg/mL (white triangles), and 0.1 μg/mL (white diamonds). The obtained SC 50 values are shown in the inset. (c) Curves obtained using fixed amounts of K4E7MoAb (0.3 μg/mL) and donor bead (7.5 μg/mL) and different amounts of protein A conjugated acceptor beads: 20 μg/mL (black squares), 10 μg/mL (black diamonds), 5 μg/mL (white triangles), and 2.5 μg/mL (white diamonds). The obtained SC 50 values are shown in the inset. (d) Curves obtained using fixed amounts of K4E7MoAb (0.3 μg/mL) and protein A conjugated acceptor bead (10 μg/mL) and different amounts of streptavidin donor beads: 30 μg/mL (black squares), 15 μg/mL (black circles), 7.5 μg/mL (white triangles), and 3.8 μg/mL (white diamonds). The obtained SC 50 's are shown in the inset.
Louis, MO). Enzyme-linked immunosorbent assay (ELISA) and dilution microtiter polystyrene plates were purchased from Greiner (Solingen, Germany).
Atrazine NanoAlphaLisa protocol. The noncompetitive nanoAlphaLisa assay was performed using protein A-coated acceptor beads, streptavidin-coated donor beads, the purified monoclonal antiatrazine antibody (MoAb) K4E7, and a biotinylated synthetic anti-immunocomplex peptide "13A" specific for the atrazine-K4E7 immunocomplex (Biotin-ASGSACTPVRWFDMC-NH 2 ). 18 Protein A was conjugated to acceptor beads as described in the Supporting Information. Atrazine standards and samples spiked with atrazine were prepared by adding 100 μL of 10× AlphaLisa Buffer (250 mM HEPES, pH 7.4, 1% casein, 10 mg/mL Dextran-500, 5% Triton X-100) to 900 μL of Milli-Q water or a water sample.
On the basis of the manufacturer's instructions and as a starting point, assay performance was explored by keeping constant the amount of donor (7.5 μg/mL) and protein A conjugated acceptor beads (10 μg/mL) and testing different amounts of K4E7MoAb captured on acceptor beads in the final assay. Protein A coated acceptor beads at 100 μg/mL were prepared for assays by preincubation with K4E7MoAb at 24, 12, 0.6, 0.3, and 0.1 μg/mL for 30 min at 25°C (mix 1) in 1× AlphaLisa buffer. At the same time, the streptavidin donor beads were preincubated with an excess of biotinylated peptide in 1× AlphaLisa buffer. For each 10 μg of streptavidin (MW = 58 kDa) donor bead, 15 μg of biotinylated peptide (MW ∼ 1.8 kDa) (3 μL) was added to a final volume of 30 μL (mix 2). The preincubation was performed on ice and protected from light exposure. Assuming that 10 μg of streptavidin coated bead was all streptavidin (0.172 nmoles), there was at least a 50-fold molar excess of biotinylated peptide. However, since only the surface of the bead is occupied by streptavidin, the molar excess of peptide to streptavidin was much higher than 50-fold. The reaction was scaled up or down depending on the required amount for each assay.
Five microliters of protein A acceptor beads preincubated with different amounts of K4E7MoAb (mixes 1) and 5 μL of streptavidin coated donor beads preincubated with synthetic biotinylated "13A" anti-immunocomplex peptide (mix 2) were dispensed in a white microtiter plate (Greiner) containing 5 μL of 10× AlphaLisa buffer and 35 μL of Milli-Q or water samples spiked with atrazine. After 15−60 min of incubation at 25°C, the reaction was read on the AlphaLisa signal reader (Fusion α-FP Packard, PerkinElmer).
NanoAlphaLisa Assay Cross-Reactivity with Other Triazines. The selectivity of the nanoAlphaLisa was explored by determining the cross-reactivity with related triazines. Crossreactant concentrations in the 0−10 000 ng/mL range were used in the noncompetitive nanoAlphaLisa. The molar compound concentration corresponding to the inflection point of the curve, which corresponds to the concentration of analyte producing 50% saturation of the signal (SC 50 ), was used to calculate the cross-reactivity of the assay according to the equation:
NanoAlphaLisa Assay with Undiluted River Water Samples, Intra-and Interassay Reproducibility. For the analysis of matrix effect, different river and mineral water samples from California, USA, with no registered use of atrazine, were spiked with known amounts of analyte and assayed by nanoAlphaLisa in the 0.3−1 ng/mL range, using 35 μL of undiluted water samples plus 5 μL of 10× AlphaLisa Buffer. Five microliters of each bead preincubated with K4E7MoAb and biotinylated peptide, respectively, were then added to the samples and incubated for 1 h. The intra-assay and interassay parameters were tested by performing three consecutive measurements of the same sample and repeated for three consecutive days, respectively.
■ RESULTS AND DISCUSSION
Development of NanoAlphaLisa Assay and Optimization. The nanoAlphaLisa assay is represented in Figure 1a ; in the presence of analyte, donor and acceptor beads are brought together. Anti-immunocomplex synthetic biotinylated peptides bound to streptavidin-coated donor bead recognize the atrazine-K4E7MoAb immunocomplex (which has been previously captured by protein A-coated acceptor bead). Upon laser excitation (680 nm), the donor bead converts ambient oxygen to an excited singlet state. Singlet oxygen diffuses up to 200 nm to produce a chemiluminescent reaction in the acceptor bead, leading to light emission (at 615 nm). Acceptor beads were conjugated to protein A with the objective of assaying different amounts of antiatrazine MoAb antibody K4E7 captured on the surface of the beads. Nanopeptamer was formed on the surface of the donor beads by incubating biotinylated synthetic anti-immunocomplex peptide for atrazine (13A) with streptavidin coated donor beads using an excess of the biotinylated peptide (see Materials and Methods). In the first experimental step for the set up of the nanoAlphaLisa assay, we chose to use different concentrations of K4E7MoAb captured on the surface of the acceptor beads, from 2.4 to 0.1 μg/mL. Standard noncompetitive atrazine curves were performed in these conditions. Taking into account the SC 50 (50% of saturation signal) as an indicator of the assay sensitivity, as antibody concentrations were lowered, luminescence signals decreased, but assay sensitivities increased regarding their SC 50 (Figure 1b) . The most sensitive assays were achieved when 0.3 μg/mL (SC 50 = 1.4 ± 0.1 ng/mL) and 0.1 μg/mL (SC 50 = 0.84 ± 0.4 ng/mL) of K4E7MoAb were captured on the surface of the acceptor bead. In light of these results, we chose to continue our work with 0.3 μg/mL of K4E7MoAb captured on the surface of the acceptor bead, since this condition resulted in higher signals and more reproducible assays (data not shown).
Next, we studied the effect of the amount of acceptor beads on the assay performance by keeping constant the amount of captured K4E7MoAb on the surface of both the acceptor beads (0.3 μg/mL) and streptavidin donor beads (7.5 μg/mL). Protein A-coated acceptor beads were assayed at 20, 10, 5, and 2.5 μg/mL (final concentration). As shown in Figure 1c , signal intensities increased in a directly proportional relation to the concentration of acceptor beads, but no significant changes in assay sensitivities were found. We decided to continue our assays with 10 μg/mL of the acceptor beads as it presented a better signal-to-noise ratio than the 20 μg/mL assay. The last parameter that was explored was the influence of streptavidin coated donor bead concentration in assay performance by keeping constant the protein A acceptor bead and K4E7MoAb concentrations at 10 and 0.3 μg/mL, respectively. Streptavidin beads were assayed at 30, 15, 7.5, and 3.8 μg/mL. The results of this last evaluation are shown in Figure 1d ; in most cases, assay performances were satisfactory and similar among assays except when 30 μg/mL of donor beads were used which yielded a poor assay. Subsequent assays revealed that the concentration
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Anal. Chem. 2018, 90, 6187−6192 of 7.5 μg/mL of streptavidin facilitated development of the most robust and reproducible assays. It is worth noting that, in all the cases in which different conditions were explored for nanoAlphaLisa assay optimization, bead proximity only occurred in the presence of atrazine. This differs with previous results obtained in standard ELISA in which background noise due to residual interaction between the anti-immunocomplex peptide and the unliganded antibody was observed during assay setup, as shown in Figure S1 . 18 Taking into account the data obtained from the optimization experiments, we chose to perform an atrazine standard curve following the same procedure as described above. In a final volume of 50 μL, atrazine standards at 2-fold dilution concentration from 12 to 0.09 ng/mL were detected using the defined bead concentrations (donor bead at 7.5 μg/mL and acceptor bead at 10 μg/mL) and 0.3 μg/mL of K4E7MoAb. The final optimized assay for atrazine is shown in Figure 2 and performed with an SC 50 of 0.5 ± 0.02 ng/mL and limit of detection (LOD), defined as the amount of atrazine that results in a signal of 10% of the saturation signal, of 0.3 ng/mL. This sensitivity is similar to that obtained with the original haptenbased competitive ELISA performed with K4E7MoAb, which exhibited an IC 50 = 0.64 ± 0.06 ng/mL and a LOD = 0.18 ng/ mL. 25 While the original ELISA took 4 h with washing steps, nanoAlphaLisa was completed within 1 h in a mix and measure mode with no washing steps.
It is well-known that AlphaLisa assays display a loss of signal when an excess of analyte is present in the sample and surpass a saturation concentration (hook point), a phenomenon known as "hook effect" and described at the manufacturer's Web site.
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Beyond the hook point, the excess of analyte disrupts associations between donor and acceptor beads causing a decrease in signal. However, in the nanoAlphaLisa assay, no hook effect was observed from 1 to 200 ng/mL of atrazine, as shown in Figure S2 . This showed that free atrazine is not bound by nanopeptamers and only atrazine complexed with K4E7MoAb on the surface of the acceptor bead is recognized by nanopeptamers. The absence of the hook effect has practical implications, since samples containing high amounts of analyte will not result in a false negative, which would be the case in a standard AlphaLisa.
In order to reduce the assay time, we explored lowering the incubation time with the objective of assessing the shortest incubation time of beads and atrazine that could still yield accurate assays. For this, we first performed standard atrazine curves in buffer prepared with Milli-Q water. As shown in Figure S3 , appropriate calibration curves were obtained when irradiating beads at 15, 30, and 45 min of incubation. However, when analyzing real water samples, the recoveries were affected with short incubation times and it was necessary to extend the incubation to 1 h.
Atrazine Determination in River Water Samples Using the NanoAlphaLisa Assay. The performance of the assay with real samples was tested using undiluted samples obtained from river and mineral water. Atrazine was spiked at 1, 0.75, 0.5, and 0.3 ng/mL, and each sample was analyzed in triplicates. The recoveries are shown in Table 1 . Very good recoveries ranging from 79 ± 2% to 124 ± 7% were obtained for all the samples, showing that the nanoAlphaLisa can be used for detection of atrazine in undiluted water samples.
The intra-assay and interassay parameters were tested by performing three consecutive measurements of the same sample and repeated for three consecutive days, respectively. As shown in Table 2 , nanoAlphaLisa for atrazine showed a very good accuracy and reproducibility. Cross-reactivities with other compounds of the triazine family were very similar to those obtained in conventional ELISA when using M13 phage particles bearing anti-immunocomplex peptides as immunoassay reagents, shown in Table 3 .
■ CONCLUSIONS
AlphaLisa assay signal generation relies on acceptor−donor bead proximity induced by the presence of the analyte, which is typically bound by antibody pairs immobilized on the surface of the beads. Small analytes cannot be bound simultaneously by two antibodies, and hence, they cannot be used to bridge the acceptor and donor beads. In this study, we demonstrated that anti-immunocomplex peptides, which react selectively with Figure 2 . NanoAlphaLisa assay for atrazine. The assay was performed in 50 μL of AlphaLisa buffer containing K4E7MoAb at 0.3 μg/mL, protein A acceptor beads at 10 μg/mL, and atrazine at 2-fold dilution concentrations. Donor beads preincubated with an excess of biotinylated synthetic peptide 13A were added, and the mixture was incubated for 1 h at 25°C. After that, beads were irradiated at 680 nm and signal was registered at 615 nm. The atrazine standard curve shows a SC 50 = 0.5 ± 0.02 ng/mL and a LOD = 0.3 ng/mL. small analyte−antibody complexes, provide sufficient stabilization of bead proximity to enable the generation of strong luminescent oxygen channeling signals. Using atrazine as a model small molecule analyte, we developed a novel immunoassay (nanoAlphaLisa) for this herbicide that allowed the sensitive mix-and-read detection of atrazine in undiluted water samples within 1 h. Given the toxicological, environmental, and medical analytical relevance of small molecules and considering that anti-immunocomplex peptides can be isolated in a straightforward manner from phage display peptide libraries, the nanoAlphaLisa presented here constitutes a valuable addition to the toolbox of rapid methods for the detection of these compounds. This methodology also has the intrinsic advantages of automation and high-throughput processing that homogeneous luminescent oxygen channeling assays provide.
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